Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03GAY
|
||||
Former ID |
DIB013185
|
||||
Drug Name |
H-409/22
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Cardiovascular disorder [ICD10:I00-I99] | Discontinued in Phase 2 | [547165] | ||
Company |
AstraZeneca plc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C28H33N5O3
|
||||
Canonical SMILES |
CC(C1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(C2=CC=CC=C<br />2)C3=CC=CC=C3
|
||||
InChI |
1S/C28H33N5O3/c1-19(20-14-16-23(34)17-15-20)32-26(35)24(13-8-18-31-28(29)30)33-27(36)25(21-9-4-2-5-10-21)22-11-6-3-7-12-22/h2-7,9-12,14-17,19,24-25,34H,8,13,18H2,1H3,(H,32,35)(H,33,36)(H4,29,30,31)/t19-,24-/m1/s1
|
||||
InChIKey |
AOUQZUZEYSDMEZ-NTKDMRAZSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Neuropeptide Y receptor type 1 | Target Info | Antagonist | [525884] | |
NetPath Pathway | FSH Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.